HIGHLIGHTS
- who: Report and collaborators from the Department of Internal Medicine, Saint University of Beirut, Beirut, LBN Department of Rheumatology, Land Hospital, Sugar Land, USA have published the Article: Review began 11/03/2022 Review ended 11/21/2022 Published 11/28/2022 u00a9 Copyright, in the Journal: (JOURNAL) of November/28,/2022
- what: The authors report a case of SRC that was unresponsive to initial ACE inhibitor treatment but showed remarkable improvement with the use of eculizumab.
- future: Studies are needed to assess the potential benefit of early treatment with complement inhibitors in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.